Industry and Academic Experts Line Up for New Bioinnovations Speaker Series
RFU announces the launch of its new BioInnovations Speaker series, which debuted on Oct. 19 in-person…
News Archive
Treating 9/11 First Responders: Can Genetics Predict Severity of PTSD?
Last September, people across the United States and the world commemorated the 20th anniversary of the 9/11 attacks…
Patent Portfolios Bridge the Gap Between Innovation and the Public Good
Entrepreneur in Residence Peter Paredes, JD, advises Helix 51 incubator companies and other startups, universities and…
Invisible and Stigmatized: What Unique Health Disparities Affect Bisexual Individuals?
Nationally representative surveys reveal that 3% of adults and 6% of adolescents in the United States…
‘Perhaps the Greatest Challenge’: How To Get Capital Behind Concepts
Michael Beaubaire, MD, who was named the first Entrepreneur in Residence for Helix 51, is the principal of Beaubaire…
Helix 51 Biomedical Innovation
The life science hub Helix 51 continues to expand its roster of startup, early-stage and international companies, adding…
CyberSole: The Science of Saving Feet
Researchers at RFU’s Center for Lower Extremity Ambulatory Research (CLEAR), in partnership with the University’s…
Behavioral Neuroscientist Joins RFU Faculty
Nicole Ferrara, PhD, a postdoctoral fellow in the lab of Brain Science Institute Director Amiel Rosenkranz, PhD, will…
Differing Pathways
Keys to Alzheimer’s might vary from male to female.
Disrupting the Way Diagnostics Are Delivered
A Helix 51 company has designed a novel way to administer and process rapid diagnostic tests in the workplace and in…